Next-Generation Sequencing: 2024 Report Highlights Clinical
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The
Exact Sciences Corporation (NASDAQ:EXAS) specializes in cancer screening and diagnostic test products, operating both in the United States and internationally.
/PRNewswire/ -- The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets" report has been added to ResearchAndMarkets.com's offering....
Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2023 financial results after the close of the...
/PRNewswire/ -- The "The World Market for Molecular Diagnostics, 12th Edition" report has been added to ResearchAndMarkets.com's offering. The World Market for...